© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Long before Formoterol Tartrate made its mark in inhalers, asthma treatment lagged behind. Days at the hospital watching families struggle with relentless coughing spells still come to mind. In the 1980s, research labs in Europe started refining formoterol’s base structure, looking for a way to push bronchodilator relief beyond the short-acting beta agonists scattered across pharmacies. Chemists spent years tweaking the basic molecule, searching for something that outlasted the two-hour window from salbutamol, and could support patients for most of the day. They landed on Formoterol Tartrate, a long-acting beta2-agonist that proved to offer stable, all-day relief. Pharmaceutical bodies then greenlit it for asthma care and COPD, forever changing the standard approach for millions.
Heading to clinics today, Formoterol Tartrate appears in metered-dose inhalers and dry powder devices. It works as a maintenance therapy for bronchospasm, rather than as an emergency rescue. I’ve seen the relief in patients’ faces who use it every twelve hours. Its quick onset sets it apart from older long-acting agents, and regulatory agencies across Europe, North America, and Asia have all acknowledged it as a safe, consistent tool—once inhaled, it settles on the lung’s smooth muscle cells, relaxing constriction and letting air move freely. Formoterol’s role has only expanded, often paired with inhaled corticosteroids for persistent asthma and as a foundation for severe COPD.
Walking into a compounding lab, one recognizes the white, crystalline solid of Formoterol Tartrate, almost odorless, sparking little immediate reaction—except for the subtle warning it carries for trained hands. The molecule is a dihydroxyphenylethanolamine derivative, its tartrate salt providing stability and solubility advantages. Chemists reference a melting point near 148°C, and its moderate water solubility supports rapid lung absorption. Being optically active, only one isomer brings out the pharmacological punch; the chemical formula locks in these features, leading to selective agonist activity at beta2 receptors with high potency.
Drug manufacturers present Formoterol Tartrate to strict technical standards: accurate dosing, low impurity thresholds, and clear stability profiles. Pharmacists pay attention to each element on the label—not just strength per dose, but potential allergens from excipients, and precise expiry dates. Clinical trials have set the optimal dose for adult maintenance at 12 micrograms twice daily, with pediatrics requiring careful adjustment. Lab notebooks mention batch verification, chromatography for purity testing, and close tracking of storage conditions to prevent loss of activity. In practice, clinicians need unambiguous instructions to minimize risk, especially given Formoterol’s potential for cardiac stimulation if misused.
On the synthesis floor, chemists assemble Formoterol’s backbone stepwise. The route starts from substituted phenylacetic acids, combines them with aliphatic sidechains through selective alkylation, and moves through reduction and protection reactions to avoid unwanted side products. Formoterol itself is isolated and purified, then combined with tartaric acid to form the salt that hits inhalers worldwide. The final API undergoes high-performance liquid chromatography to catch micro-level contaminants, before blending with excipients to make inhalable powder or aerosol formulations. I’ve watched as these processes drove endless rounds of quality assurance—one slip, and substandard drugs risk hitting the market, compromising patient trust and safety.
Formoterol’s molecular framework permits tailored modifications. Chemists have explored substitutions on its phenyl ring, probing activity at adrenergic receptors, and adjusting alkyl chains for metabolic resilience. Early experiments found side chain length and stereochemistry vital for maximizing the bronchodilatory effect while minimizing unwanted tachycardia. Over time, researchers have avoided complex derivatization that would add toxicity, focusing on minor changes that tweak absorption or duration. Transformation to different salt forms, like fumarate and hydrochloride, have entered discussion, but tartrate balances stability and patient tolerance best, securing its role in most commercial products.
Pharmacists and healthcare providers run into a handful of synonyms in the literature: eformoterol, CG 13113, NAFOR, and Foradile, among others. Each product name reflects a different source or country. I’ve encountered confusion at the pharmacy counter, where brand and generic identities occasionally baffle patients. Education becomes critical—the compound’s action, not the marketing name, determines care. Still, the bulk of prescriptions ride under the Formoterol Tartrate or Formoterol Fumarate name, anchoring its identity worldwide.
Formoterol Tartrate, in skilled hands, delivers safety confirmed by decades of post-marketing surveillance. Still, overstimulation of cardiac beta receptors can cause palpitations and tremor, especially if underlying heart disease or arrhythmias go unnoticed. In my practice, patients with hypertension or known arrhythmias demand extra caution. Safety protocols demand training for nurses, respiratory technicians, and patients, with regular updates reflecting new clinical findings. Operational integrity in the pharmaceutical supply chain keeps counterfeit products away, while strict auditing from the regulatory side upholds dosing and purity.
Formoterol Tartrate carved its main territory in respiratory care. Asthma and COPD account for most prescriptions, yet there’s growing evidence for its role in treating exercise-induced bronchospasm and other chronic airway diseases. Emergency physicians recognize its fast onset paired with long action, making it essential for education in self-management plans. The mix with corticosteroids in combination products has proven key for keeping inflammation and constriction in check, and it’s now routine to see these combinations at every outpatient pulmonology visit. Across primary care and hospital settings, clinicians value formoterol’s reliability in helping patients regain control over their lung health and daily life.
Pharmaceutical science hasn’t rested. Formoterol’s arrival in the 1990s illustrated how incremental gains—a faster onset, longer duration—could translate into patient wins. Modern labs still refine the molecule for once-daily dosing and better pairing with emerging corticosteroids. Research groups chase delivery systems that reduce dose variability, cut down on device mishandling, and ensure deep lung deposition. Clinical studies look at pediatric, elderly, and at-risk populations, testing not just lung function but quality of life and hospitalization rate reduction. These data have steered regulatory guidance and shaped the modern asthma and COPD guidelines, making the drug a study subject as much as a treatment staple.
Extensive animal studies estimated an LD50 far outside normal therapeutic use—good news, though rare genetic factors can amplify risk. Human studies focus on cardiac risk, particularly arrhythmias at high doses, and interactions with other bronchodilators or depressants. Case reports on overdose describe tremor, headache, and occasional seizures, justifying close patient education on maximum inhalations per day. The drug’s safety margin works best with education: teaching patients not to double-dose or substitute for rescue inhaler. Doctors, nurses, and pharmacists act as gatekeepers, watching for warning signs and triaging appropriately if adverse reactions crop up.
Looking ahead, Formoterol Tartrate stands as more than a mainstay in respiratory care. There’s talk in research circles to pair it with novel anti-inflammatory agents, or design triple therapies combining bronchodilation, inflammation reduction, and anti-allergic effects in one device. Attention grows around its place in personalized medicine—adjusting doses depending on genotype, phenotype, or even environmental triggers. Inhaler technology marches forward, promising digital monitoring and feedback on inhalation quality, which would reduce wastage, improve compliance, and keep emergency rooms less crowded. These innovations show scientists and clinicians aren’t finished refining how we support respiratory patients, and Formoterol Tartrate remains in the center of these efforts, its importance shaped and tested by the real lives behind the prescriptions.
For people living with asthma and chronic obstructive pulmonary disease (COPD), just catching a breath can turn into a challenge. Wheezing, tightness in the chest, and coughing fit into everyday life, making what should be ordinary activities almost impossible. I’ve seen family members double over trying to breathe during an asthma attack. Nobody should have to feel like air is out of reach. That struggle drives many toward medications like Formoterol Tartrate.
Formoterol Tartrate comes from a group of drugs called long-acting beta-agonists, or LABAs. Its main job is to open up narrowed airways. By relaxing the smooth muscles lining the passageways in the lungs, it makes air flow easier. The relief doesn’t just last a few minutes. With regular use, it can keep symptoms away for as long as twelve hours. For someone grappling with asthma, knowing the medicine will keep working through the night brings a kind of peace that counts for a lot.
I remember the days of rushing for an inhaler for fast relief. Fast-acting inhalers still save lives in emergencies. Formoterol isn’t the rescue option—it gets used as part of a long-term plan. After starting routine use, I’ve noticed people stop dreading surprise triggers as much—outdoor exercise, cold air, or allergens don’t always mean reaching for that emergency inhaler. Formoterol does its part in the background, helping to prevent flare-ups before they start.
Medical researchers point to large studies that back up its benefit for people whose symptoms need more than a corticosteroid inhaler alone. Folks who wind up in the ER over and over, or wake during the night struggling for breath, tend to see improvement once their doctor adds a LABA to their routine. I’ve talked to patients who, after switching to a combined inhaler with Formoterol, finally felt stable enough to make long-term plans and travel.
No medication comes free of risks. Formoterol can sometimes cause heart palpitations or tremors. Some older studies made waves over a possible increased risk of death from asthma if Formoterol got used alone, especially without a steroid. These days, doctors nearly always prescribe it together with an inhaled steroid—either as two separate inhalers or, more often, as a single combination product. This strategy keeps patients safe and their airways protected from both tightness and inflammation.
Not everyone who could use Formoterol Tartrate gets it. Insurance hurdles, awareness, and affordability lock out too many. Doctors and pharmacists must keep pushing for better education and accessible solutions, both for patients in big cities and those in rural areas who see a specialist far less often. Big steps forward have already come from combination inhalers that blend Formoterol with steroids, giving people what they need in one device. But there’s still ground to cover to make breathing easy for more people, wherever and whoever they are.
I’ve seen plenty of folks rush through their inhaler routine. Nobody loves fiddling with gadgets when you’re short of breath. But I can say from my own experience as someone dealing with asthma, pausing to use Formoterol Tartrate the right way pays off in reliable relief. Formoterol belongs to a type of medication called long-acting beta-agonists. It helps open up tight airways and keeps symptoms like coughing or wheezing from sending another trip to the ER.
Most mistakes happen from habit. I've seen people skip the “shake before use” step or forget to exhale before inhaling the medicine. These details sound small, but skipping them puts your lungs at a disadvantage. A well-used inhaler delivers each dose deep in the lungs, where it does the actual work. A slapdash approach means you’re probably just spraying medicine into your mouth, not your airways.
With Formoterol, once or twice daily—at around the same times—sets a stable foundation. The goal isn’t to chase down symptoms but to head them off before they start. More puffs don’t equal more protection. I’ve watched friends panic during a flare-up and double-dose out of fear, not realizing that Formoterol won’t work like rescue medicine. Overuse cranks up the risk for heart palpitations and shaky hands without offering extra help.
Every label includes step-by-step instructions for a reason. Cap comes off. Shake the device. Exhale away from the mouthpiece. Hold the inhaler upright. Seal lips around the piece and start breathing in slow and deep. That timing can feel tricky, but the smooth inhale gives medicine an expressway into the lungs. Some inhalers click or make a noise that signals a dose went through—those cues matter. After the inhale, holding the breath for about ten seconds gives the medicine a chance to settle in.
I learned to rinse my mouth out after each use. Skipping this led to throat irritation and mouth sores more than once. It’s a hassle, but it helps prevent side effects that sneak up after using steroid combo inhalers.
A responsible doctor hands out a plan, not just a prescription. The pharmacist or doctor can walk through a demo if you ask. One friend brought their inhalers to every visit for a quick check on technique. Online videos can reinforce that education. It's not about going it alone. Many communities and support groups offer peer tips and reminders.
If symptoms keep breaking through—wheezing, nighttime coughing, using rescue inhaler lots more—it’s not the medicine failing. It’s a call to look again at the plan. Maybe there’s a missed step or a trigger at home or work nobody noticed. Sometimes, a doctor needs to rethink the medication set-up. Communication matters more than ever. I had to admit to my physician that I sometimes skipped a dose; it made a difference in finding a better fit for my schedule and symptoms.
Using Formoterol Tartrate isn’t just about following instructions—it’s about giving yourself the best shot at steady breathing. The little things add up. Technique, timing, washing up after: they all stack together for better lung health. Doctors, pharmacists, and even friends with the same prescription can teach a lot about making every puff count.
Formoterol tartrate has been keeping many folks with asthma and COPD out of the emergency room for years. It’s one of those long-acting bronchodilators that can help people actually climb a hill or play with grandkids, instead of sitting out most of family life. Speaking with people at the pharmacy, you start to notice a few patterns. Some say they feel their heart race just after a dose. Others mention a jittery feeling or a mild headache, almost like they had an extra coffee on an empty stomach. These experiences aren't rare. The most common side effects stem from its role as a beta-2 agonist—expect nervousness, shakiness, headaches, faster heartbeat, and on occasion, a cough right after inhalation.
The FDA and European Medicines Agency both require that these kinds of warnings stay front and center. You can find them right on the printout from the pharmacist. Dry mouth, muscle cramps, and trouble sleeping come up enough that every patient should know to expect them at least once.
Taking care of people who rely on inhalers teaches you to watch for more than just the nagging symptoms. Once in a while, someone feels chest pain or their heart seems to skip a beat. Those aren’t the sort of things to brush off. There’s a risk of serious events—irregular heart rhythm, or even paradoxical bronchospasm, where instead of breathing easier, things get much worse. A handful in every thousand end up in the emergency room every year because they decided the new fluttering feeling in their chest could wait.
There’s also this tricky side effect—low potassium. It doesn’t shout at you like a racing heart, but if you already take medications that lower potassium or if your diet’s light on fruits and veggies, trouble sneaks up fast. Symptoms—weakness, leg cramps, or just not feeling like yourself—could lead to a real problem if ignored. That's why every doctor worth their salt says “check your labs” once in a while if you’re taking this long-term.
A lot of people stop their medication when a side effect crops up, which can cause a spiral of worse breathing and recurring symptoms. Healthcare providers are supposed to check in, ask about side effects, and adjust the plan when needed. Those conversations don’t always get the time they deserve. In my own work with patients, checking in by phone or text every so often made a bigger difference than any fancy app or brochure.
It’s not just about listing out the risks. Good evidence shows that teaching folks how to use their inhaler makes a huge difference. Improper technique leads to side effects, mainly because most of the medicine lands on the tongue instead of the lung. That’s something pharmacists and doctors can fix in ten minutes with a demo—saving months of headaches, cough, or throat irritation.
The job isn’t just to warn, it’s to give tools for better choices. For anyone with a personal or family history of heart disease, talking with a provider before starting formoterol tartrate matters. Adjusting other meds—especially diuretics or beta-blockers—lowers the chance of complications. Data shows people do best with regular check-ups, open lines of communication, and a care team that listens.
Balancing risks and benefits becomes easier with honest dialogue—between patient, provider, and even among family members at home. For most, the relief from shortness of breath far outweighs the discomfort, but only when the support and knowledge are there as well.
Formoterol tartrate often enters the picture for people with asthma or chronic obstructive pulmonary disease (COPD). Its effect can last for about twelve hours, so it earns a place in long-term respiratory plans, helping to keep airways open. Many who use this drug also take other types of medications to manage symptoms day and night. It’s rare to meet someone with COPD or severe asthma who gets by with only one prescription. So, it makes sense to ask: can formoterol tartrate work safely with other drugs?
Doctors look at a person’s entire list of medications before adding something new. That’s because certain combinations can bump up side effects or lessen the help each drug gives. With formoterol tartrate, common partners on a prescription list often include inhaled corticosteroids, like budesonide or fluticasone. People benefit from these combinations. Inhaled steroids keep swelling in check, while formoterol opens up the airways, letting that medicine reach deeper into the lungs. This approach shows up in popular combination inhalers approved by the FDA, so the safety record’s there.
Oral medications also join the party sometimes. Montelukast, an oral pill, does a decent job of blocking inflammation signals, while formoterol tartrate keeps airways relaxed. Together, patients might find greater symptom improvements than with either medicine alone.
Of course, not all combinations fit everyone. Beta-blockers—often given for heart disease or high blood pressure—clash with formoterol tartrate. Both drugs butt heads over the same body systems, and one can cancel out the other’s effect. That’s not safe for people relying on these medicines to breathe or protect their heart. The story gets more complicated with other drugs too, especially those that change how fast the liver breaks things down, such as ketoconazole or ritonavir. These medicines might cause formoterol tartrate concentrations to spike, leading to a racing heartbeat or shakes. In rare cases, trouble with potassium levels crops up if someone takes certain diuretics alongside formoterol tartrate. That can bring muscle cramps or even heart rhythm problems.
Real stories underline the importance of these drug interactions. A neighbor of mine once found out the hard way after starting a new heart medicine. His breathing got worse, not better. Turns out, his beta-blocker and inhaler were fighting against each other. His doctor caught the problem and switched medications, but it took days for his lungs to recover.
Doctors use drug interaction checkers when adding new prescriptions, but patients have a part to play too. People should list every medicine they use—including over-the-counter drugs and supplements—when filling out medical forms. Pharmacists catch mistakes doctors might miss, as they look at dozens of prescriptions in a day. Bringing inhalers to every appointment helps, too. With clear communication, formoterol tartrate can be safely paired with many treatments.
Smartphone apps now allow users to keep track of possible dangers from mixing drugs. Reliable resources, like the U.S. National Library of Medicine and FDA drug fact sheets, offer detailed information for anyone curious. Respiratory specialists follow research for updates, and new combination inhalers sometimes reduce risk by delivering two medicines in one device, set at safe doses.
Lung disease challenges a person’s life every day, but mixing the right medicines—under watchful guidance—prevents emergencies and cuts down on trips to the hospital. Tools exist to help, but nothing replaces the value of personal relationships with thoughtful doctors, pharmacists, and caregivers. By staying informed and asking questions, people get the best of modern medicine, with fewer surprises along the way.
Formoterol Tartrate treats asthma and chronic obstructive pulmonary disease by relaxing muscles in the airways. It gets prescribed for quick symptom control and long-term maintenance. On prescription labels, it shows up in inhalers and combination medications. Its speed attracts doctors who need to help struggling patients breathe easier.
Family routines often get turned upside down when a child fights to breathe. Giving any strong medicine to a kid always raises questions. Pediatricians stick close to strict guidelines because kids’ bodies break down drugs differently than adults. For children six and up, some guidelines do allow Formoterol Tartrate, mostly in combination with inhaled steroids. Pure Formoterol inhalers almost never go to young kids.
Respiratory specialists watch for side effects like fast heart rate, nervousness, and headaches in children. Rarely, kids experience worsening asthma—sometimes called “paradoxical bronchospasm”—which can send families rushing back to the emergency room. Safety studies in children aren't as extensive as those done for adults, so doctors choose alternatives when possible and keep doses conservative. Families should always talk with a pediatric pulmonologist before starting Formoterol, and report any jitters, rapid heartbeats, or chest pain.
The FDA and European regulators have set age minimums and endorse using Formoterol only for asthma not controlled well by other means. Asthma action plans should be updated before adding long-acting bronchodilators to a child’s daily routine.
Any expectant mother who’s been through an asthma flare knows the anxiety that follows. Oxygen for both mom and baby matters every minute. The challenge is that pregnancy brings its own changes—heart rate, blood flow, and sensitivity to medications shift each trimester.
Formoterol Tartrate has not been studied in pregnant women as closely as common older inhaled beta-agonists. Most safety data comes from animal studies, and those don't always predict what happens in real pregnancies. Doctors prefer to stick with drugs that have longer safety records, especially during the first trimester. Major groups like the American College of Obstetricians and Gynecologists favor inhaled corticosteroids over long-acting beta-agonists. They suggest using Formoterol if symptoms remain unmanageable with other treatments and only under close observation.
Doctors weigh risks and benefits. Severe asthma can threaten both baby and mother, so sometimes the best choice is the one that keeps attacks under control. Women should have open, honest conversations with obstetricians, including what to do if symptoms worsen at night or during physical activity.
I remember a close friend worried sick about her son, who battled wheezing every spring. Their allergy season meant trips to pediatric specialists, whose careful planning and regular checkups made the difference. Whenever a new inhaler entered the picture, she kept detailed notes about sleep changes, mood, and energy. Every parent knows “gut instinct” counts. No matter what medication gets prescribed, open doors to your child’s care team: phone calls, updates, and even second opinions.
Pregnancy brings a whole different layer of uncertainty. I’ve seen expecting mothers in my own circle talk through medication changes at every checkup. Those appointments brought a sense of relief—knowing someone is keeping two heartbeats safe. Good asthma control protects both lives, but every new prescription deserves close monitoring.
Families and mothers-to-be need up-to-date asthma action plans. Ask for printed instructions. Track symptoms in a journal or phone note. Always bring up concerns quickly—in asthma, small changes can matter a lot. Pharmacists offer extra guidance and can answer questions about combinations, timing, or missed doses. Medical teams rely on families to report how kids and expectant mothers truly feel on Formoterol. Good records, regular follow-up, and shared decision-making help protect everyone’s health.
| Names | |
| Preferred IUPAC name | (±)-N-(2-Hydroxy-5-[(1RS)-1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl)formamide; 2,3-dihydroxybutanedioic acid |
| Other names |
Eformoterol Foradil Oxeze Perforomist |
| Pronunciation | /fɔːrˈmɒtərɒl ˈtɑːrtreɪt/ |
| Identifiers | |
| CAS Number | 124934-36-9 |
| Beilstein Reference | 127685 |
| ChEBI | CHEBI:31527 |
| ChEMBL | CHEMBL1200980 |
| ChemSpider | 24778414 |
| DrugBank | DB01412 |
| ECHA InfoCard | 03c7402cdab2-41d0-bbba-778fc0ce66a2 |
| EC Number | 80689-35-4 |
| Gmelin Reference | 857348 |
| KEGG | C14414 |
| MeSH | D000068878 |
| PubChem CID | 21834835 |
| RTECS number | YX9478000 |
| UNII | 0KX82JF64G |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C42H60N4O14 |
| Molar mass | 840.88 g/mol |
| Appearance | White or almost white powder |
| Odor | Odorless |
| Density | 1.2 g/cm³ |
| Solubility in water | Freely soluble in water |
| log P | 1.3 |
| Acidity (pKa) | 9.81 |
| Basicity (pKb) | 7.9 |
| Magnetic susceptibility (χ) | -6.2 × 10⁻⁶ cm³/mol |
| Dipole moment | 2.8 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 437.1 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -189.7 kJ/mol |
| Pharmacology | |
| ATC code | R03AC13 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause allergy or asthma symptoms or breathing difficulties if inhaled. May cause respiratory irritation. |
| GHS labelling | GHS labelling of Formoterol Tartrate: "Warning; H302, H319, H335; P261, P264, P270, P305+P351+P338, P337+P313 |
| Pictograms | GHS06, GHS08 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H334, H335 |
| Precautionary statements | Keep out of reach of children. If medical advice is needed, have product container or label at hand. Read label before use. |
| Flash point | Formoterol Tartrate has a flash point of 258.7 °C |
| Lethal dose or concentration | LD₅₀ (oral, rat): >2000 mg/kg |
| LD50 (median dose) | LD50 (median dose) for Formoterol Tartrate: "680 mg/kg (rat, oral) |
| NIOSH | WX8C9F10A8 |
| PEL (Permissible) | Not Established |
| REL (Recommended) | 12 mcg |
| Related compounds | |
| Related compounds |
Formoterol Arformoterol Salmeterol Indacaterol Olodaterol Vilanterol |
